VijayYajnikMD
Gastroenterology • Boston, MAAssistant Professor of Medicine, Massachusetts General Hospital
Dr. Yajnik is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St Blk 4
Gastroenterology Associates
Boston, MA 02114Phone+1 617-724-6005Fax+1 617-726-3080
Education & Training
Massachusetts General HospitalFellowship, Gastroenterology, 1998 - 2001- Massachusetts General HospitalResidency, Internal Medicine, 1996 - 1998
New York University School of MedicineClass of 1996
Certifications & Licensure
MA State Medical License 1999 - 2018
Clinical Trials
- Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis Start of enrollment: 2012 Feb 01
- Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease Start of enrollment: 2014 Feb 01
- GI Complications in Cancer Immunotherapy Patients Start of enrollment: 2015 Aug 01
Publications & Presentations
PubMed
- 645 citationsTreg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses.Nicole Joller, Ester Lozano, Patrick R. Burkett, Bonny Patel, Sheng Xiao
Immunity. 2014-04-17 - 73 citationsDifferential effect of genetic burden on disease phenotypes in Crohn's disease and ulcerative colitis: analysis of a North American cohort.Ashwin N. Ananthakrishnan, Hailiang Huang, Deanna D. Nguyen, Jenny Sauk, Vijay Yajnik
The American Journal of Gastroenterology. 2014-03-01 - 1166 citationsHedgehog is an early and late mediator of pancreatic cancer tumorigenesisSarah P. Thayer, Marina Pasca di Magliano, Patrick W. Heiser, Corinne M. Nielsen, Drucilla J. Roberts
Nature. 2003-10-23
Journal Articles
- Differences in Clinical Course, Genetics, and the Microbiome Between Familial and Sporadic Inflammatory Bowel DiseasesHamed Khalili, John J Garber, Ramnik J Xavier, Ashwin N Ananthakrishnan, Vijay Yajnik, Journal of Crohn's and Colitis
Press Mentions
FDA to Review SC Formulation of Vedolizumab for Ulcerative ColitisApril 27th, 2023
Innovations in Inflammatory Bowel DiseaseFebruary 10th, 2016
Worcester Doctor’s Medical License SuspendedMay 23rd, 2018
Grant Support
- Identification Of Genes Involved In Cancer ProgressionNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2006
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
